Literature DB >> 3498033

HLA antigens in seronegative spondylarthropathies. Reactive arthritis and arthritis in ankylosing spondylitis: relation to gut inflammation.

H Mielants, E M Veys, R Joos, L Noens, C Cuvelier, M De Vos.   

Abstract

The prevalence of HLA-A, B, C and DR antigens was determined and compared in 94 patients with reactive arthritis, 54 patients with ankylosing spondylitis (AS), 37 patients with inflammatory bowel disease (IBD) and in 1,010 apparently normal blood donors. The 185 patients all underwent ileocolonoscopy with biopsy of ileum, ileocecal valve and cecum. HLA-B27 was found elevated in the groups with reactive arthritis (48%, chi 2 = 82, p less than 0.0005) and the AS groups (78%, chi 2 = 157, p less than 0.0005), compared to healthy controls. HLA-Bw62 was significantly raised in the patients with reactive arthritis (34%, chi 2 = 73, p less than 0.0005) (particularly the HLA-B27 negatives (48%, chi 2 = 90, p less than 0.0005) and in the HLA-B27 negative patients with AS (25%, chi 2 = 5.5, p less than 0.02). This did not apply to the other patients with AS (4.7% NS). HLA-Bw62 could be associated with a specific clinical picture of asymmetrical pauciarticular arthritis, accompanied by enthesopathies and sacroiliitis classified as idiopathic reactive arthritis, especially when the disease is of enterogenic origin. The frequency of HLA-Bw62 was very high in patients with reactive arthritis and in patients with AS with active chronic (n = 39, 23%, chi 2 = 13, p less than 0.0005) and Crohn-like lesions (n = 14, 50%, chi 2 = 35, p less than 0.0005) on gut biopsy, normal in patients with acute lesions (n = 35, 11%, NS).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3498033

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  13 in total

1.  Major histocompatibility complex class II antigen (HLA-DR) expression by ileal epithelial cells in patients with seronegative spondylarthropathy.

Authors:  C Cuvelier; H Mielants; M De Vos; E Veys; H Roels
Journal:  Gut       Date:  1990-05       Impact factor: 23.059

Review 2.  An update on the contribution of the MHC to AS susceptibility.

Authors:  John D Reveille
Journal:  Clin Rheumatol       Date:  2014-05-18       Impact factor: 2.980

Review 3.  Juvenile onset spondyloarthropathies: therapeutic aspects.

Authors:  R Burgos-Vargas
Journal:  Ann Rheum Dis       Date:  2002-12       Impact factor: 19.103

Review 4.  Ankylosing spondylitis: an overview.

Authors:  J Sieper; J Braun; M Rudwaleit; A Boonen; A Zink
Journal:  Ann Rheum Dis       Date:  2002-12       Impact factor: 19.103

5.  Increase of HLA-DRB1*0408 and -DQB1*0301 in HLA-B27 positive reactive arthritis.

Authors:  J Tuokko; H Reijonen; J Ilonen; K Anttila; S Nikkari; T Möttönen; U Yli-Kerttula; A Toivanen
Journal:  Ann Rheum Dis       Date:  1997-01       Impact factor: 19.103

6.  Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome maps to chromosome 15q.

Authors:  H B Yeon; N M Lindor; J G Seidman; C E Seidman
Journal:  Am J Hum Genet       Date:  2000-03-21       Impact factor: 11.025

7.  Expression of T cell receptors alpha beta and gamma delta in the ileal mucosa of patients with Crohn's disease and with spondylarthropathy.

Authors:  C A Cuvelier; N De Wever; H Mielants; M De Vos; E M Veys; H Roels
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

8.  Effect of HLA-B and HLA-DR genes on susceptibility to and severity of spondyloarthropathies in Mexican patients.

Authors:  G Vargas-Alarcón; J D Londoño; G Hernández-Pacheco; C Pacheco-Tena; E Castillo; M H Cardiel; J Granados; R Burgos-Vargas
Journal:  Ann Rheum Dis       Date:  2002-08       Impact factor: 19.103

9.  Symptomatic cerebral microangiopathy preceding initial manifestation of ulcerative colitis.

Authors:  C Dejaco; E Fertl; D Prayer; G Oberhuber; J Wyatt; C Gasché; A Gangl
Journal:  Dig Dis Sci       Date:  1996-09       Impact factor: 3.199

10.  Treatment of non-steroidal anti-inflammatory drug induced enteropathy.

Authors:  I Bjarnason; N Hopkinson; G Zanelli; P Prouse; P Smethurst; J M Gumpel; A J Levi
Journal:  Gut       Date:  1990-07       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.